Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

GH Research is scheduled to update on the FDA status of GH001 and outline its global Phase 3 plans for treatment-resistant ...

New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

Forbes contributors publish independent expert analyses and insights. Mark Travers writes about the world of psychology. Treatment-resistant depression, or TRD, is a severe condition that can ...

Share on Pinterest New research finds that ketamine may be a more effective treatment for severe depression than electroconvulsive therapy. damircudic/Getty Images A new study compares ketamine with ...

Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug.